Evidence map›Paper›PMID 42115729›Full record

ArticleScientific reports2026

Nuclear protein 1 is a cell death regulator in primary human airway epithelial cells and reduced in idiopathic pulmonary fibrosis.

Marie Zöller, Michal Mastalerz, Elisabeth Dick, Juliane Merl-Pham, Elisabeth Hennen, Sai Rama Sridatta Prakki, Ashesh Chakraborty, Misako Nakayama, Markus Klotz, Hannah Marchi and 14 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Marie ZöllerComprehensive Pneumology Center with the CPC-M bioArchive and Institute of Lung Health and Immunity, Member of the German Center of Lung Research (DZL), Helmholtz-Zentrum München, Munich, Germany.
Michal MastalerzComprehensive Pneumology Center with the CPC-M bioArchive and Institute of Lung Health and Immunity, Member of the German Center of Lung Research (DZL), Helmholtz-Zentrum München, Munich, Germany.
Elisabeth DickComprehensive Pneumology Center with the CPC-M bioArchive and Institute of Lung Health and Immunity, Member of the German Center of Lung Research (DZL), Helmholtz-Zentrum München, Munich, Germany.
Juliane Merl-PhamMetabolomics and Proteomics Core, Helmholtz Munich, Munich, Germany.
Elisabeth HennenComprehensive Pneumology Center with the CPC-M bioArchive and Institute of Lung Health and Immunity, Member of the German Center of Lung Research (DZL), Helmholtz-Zentrum München, Munich, Germany.
Sai Rama Sridatta PrakkiResearch Unit Precision Regenerative Medicine, Comprehensive Pneumology Center, Helmholtz Munich, Munich, Germany.
Ashesh ChakrabortyComprehensive Pneumology Center with the CPC-M bioArchive and Institute of Lung Health and Immunity, Member of the German Center of Lung Research (DZL), Helmholtz-Zentrum München, Munich, Germany.
Misako NakayamaComprehensive Pneumology Center with the CPC-M bioArchive and Institute of Lung Health and Immunity, Member of the German Center of Lung Research (DZL), Helmholtz-Zentrum München, Munich, Germany.
Markus KlotzComprehensive Pneumology Center with the CPC-M bioArchive and Institute of Lung Health and Immunity, Member of the German Center of Lung Research (DZL), Helmholtz-Zentrum München, Munich, Germany.
Hannah MarchiCore Facility Statistical Consulting, Helmholtz Munich, Munich, Germany.
Ronan LeGleutCore Facility Statistical Consulting, Helmholtz Munich, Munich, Germany.
Laurens J De SadeleerLaboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department Chrometa, KU Leuven, Leuven, Belgium.
Wim A WuytsLaboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department Chrometa, KU Leuven, Leuven, Belgium.
Bart M VanaudenaerdeLaboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department Chrometa, KU Leuven, Leuven, Belgium.
Aicha JeridiComprehensive Pneumology Center with the CPC-M bioArchive and Institute of Lung Health and Immunity, Member of the German Center of Lung Research (DZL), Helmholtz-Zentrum München, Munich, Germany.
Antje PrasseDepartment of Pulmonology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
Benedikt JägerDepartment of Pulmonology, Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
Patricia Santofimia-CastañoPancreatic Cancer, Cancer Research Centre of Marseille, Institute Paoli-Calmettes, Aix-Marseille University, Marseille, France.
Mircea-Gabriel StoleriuComprehensive Pneumology Center with the CPC-M bioArchive and Institute of Lung Health and Immunity, Member of the German Center of Lung Research (DZL), Helmholtz-Zentrum München, Munich, Germany.
Anne HilgendorffComprehensive Pneumology Center with the CPC-M bioArchive and Institute of Lung Health and Immunity, Member of the German Center of Lung Research (DZL), Helmholtz-Zentrum München, Munich, Germany.
Stefanie M HauckMetabolomics and Proteomics Core, Helmholtz Munich, Munich, Germany.
Ali Ö YildirimComprehensive Pneumology Center with the CPC-M bioArchive and Institute of Lung Health and Immunity, Member of the German Center of Lung Research (DZL), Helmholtz-Zentrum München, Munich, Germany.
Herbert SchillerResearch Unit Precision Regenerative Medicine, Comprehensive Pneumology Center, Helmholtz Munich, Munich, Germany.
Claudia A Staab-WeijnitzComprehensive Pneumology Center with the CPC-M bioArchive and Institute of Lung Health and Immunity, Member of the German Center of Lung Research (DZL), Helmholtz-Zentrum München, Munich, Germany. claudia.staab-weijnitz@cuanschutz.edu.

Funding

Deutsche Forschungsgemeinschaft GRK2338European Research Council Marie Sklodowska-Curie postdoctoral fellowshipUniversity of Colorado Faculty Start-up package
6 · The paper itself

Abstract

The airway epithelium is the first site of injury from cigarette smoke (CS), a major risk factor for chronic lung disease including idiopathic pulmonary fibrosis (IPF). Here, we report the first intracellular proteomic analysis of CS exposure in fully differentiated primary human bronchial epithelial cells (phBECs). Following pathway enrichment analysis, we identified nuclear protein 1 (NUPR1) as a candidate regulator of epithelial stress responses. In contrast to the prediction by pathway enrichment analysis, NUPR1 activity was not altered by CS in vitro. Nevertheless, inhibition of its nuclear translocation using ZZW-115 revealed a cytoprotective and anti-apoptotic role in phBECs, as demonstrated by increased apoptosis and impaired epithelial integrity. NUPR1 expression was markedly reduced in IPF whole lung tissue and bronchial epithelium. IPF-derived basal cells differentiated into an epithelium exhibiting fewer ciliated and more secretory cells which exhibited significantly higher sensitivity to NUPR1 inhibition. Our findings underscore cell type- and tissue-specific variation in NUPR1-dependent pathways. Collectively, this study positions NUPR1 as a context-dependent epithelial stress regulator whose loss may contribute to epithelial vulnerability in IPF.

Indexed as

Basic Helix-Loop-Helix ProteinsDNA-Binding ProteinsEpithelial CellsIdiopathic Pulmonary FibrosisNeoplasm ProteinsRespiratory MucosaApoptosisBronchiCell DifferentiationCells, CulturedHumansProteomicsBasic Helix-Loop-Helix ProteinsDNA-Binding ProteinsNeoplasm ProteinsNUPR1 protein, humanALI cultureBronchial epitheliumCigarette smokeIn vitroIPFNUPR1

Identifiers

PMID42115729
PMCPMC13161242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.